Literature DB >> 7808465

Creatine metabolism and the consequences of creatine depletion in muscle.

M Wyss1, T Wallimann.   

Abstract

Currently, considerable research activities are focussing on biochemical, physiological and pathological aspects of the creatine kinase (CK)-phosphorylcreatine (PCr)-creatine (Cr) system (for reviews see [1,2]), but only little effort is directed towards a thorough investigation of Cr metabolism as a whole. However, a detailed knowledge of Cr metabolism is essential for a deeper understanding of bioenergetics in general and, for example, of the effects of muscular dystrophies, atrophies, CK deficiencies (e.g. in transgenic animals) or Cr analogues on the energy metabolism of the tissues involved. Therefore, the present article provides a short overview on the reactions and enzymes involved in Cr biosynthesis and degradation, on the organization and regulation of Cr metabolism within the body, as well as on the metabolic consequences of 3-guanidinopropionate (GPA) feeding which is known to induce a Cr deficiency in muscle. In addition, the phenotype of muscles depleted of Cr and PCr by GPA feeding is put into context with recent investigations on the muscle phenotype of 'gene knockout' mice deficient in the cytosolic muscle-type M-CK.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7808465     DOI: 10.1007/bf01267947

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  110 in total

1.  Transamidinase activities, in vitro, of tissues from various mammals and from rats fed protein-free, creatine-supplemented and normal diets.

Authors:  J F VAN PILSUM; B OLSEN; D TAYLOR; T ROZYCKI; J C PIERCE
Journal:  Arch Biochem Biophys       Date:  1963-03       Impact factor: 4.013

2.  Transamidination in the nephrectomized rat.

Authors:  W H HORNER
Journal:  J Biol Chem       Date:  1959-09       Impact factor: 5.157

3.  Voltage gating of the mitochondrial outer membrane channel VDAC is regulated by a very conserved protein.

Authors:  M Y Liu; M Colombini
Journal:  Am J Physiol       Date:  1991-02

Review 4.  Creatine: biosynthesis, regulation, and function.

Authors:  J B Walker
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1979

5.  Experimental depletion of creatine and phosphocreatine from skeletal muscle.

Authors:  C D Fitch; M Jellinek; E J Mueller
Journal:  J Biol Chem       Date:  1974-02-25       Impact factor: 5.157

6.  The conversion of creatinine by creatininase of bacterial origin.

Authors:  H G Eyk; R J Vermaat; H J Leijnse-Ybema; B Leijnse
Journal:  Enzymologia       Date:  1968-03

7.  A bioassay for thyroxine based on rat kidney transamidinase activities.

Authors:  J F Van Pilsum; M Carlson; J R Boen; D Taylor; B Zakis
Journal:  Endocrinology       Date:  1970-12       Impact factor: 4.736

Review 8.  Localization and function of M-line-bound creatine kinase. M-band model and creatine phosphate shuttle.

Authors:  T Wallimann; H M Eppenberger
Journal:  Cell Muscle Motil       Date:  1985

9.  A gated 31P NMR study of tetanic contraction in rat muscle depleted of phosphocreatine.

Authors:  E A Shoubridge; G K Radda
Journal:  Am J Physiol       Date:  1987-05

10.  Functional coupling between sarcoplasmic-reticulum-bound creatine kinase and Ca(2+)-ATPase.

Authors:  P Korge; S K Byrd; K B Campbell
Journal:  Eur J Biochem       Date:  1993-05-01
View more
  28 in total

1.  Inhibition of cytosolic and mitochondrial creatine kinase by siRNA in HaCaT- and HeLaS3-cells affects cell viability and mitochondrial morphology.

Authors:  Holger Lenz; Melanie Schmidt; Vivienne Welge; Thomas Kueper; Uwe Schlattner; Theo Wallimann; Hans-Peter Elsässer; Klaus-Peter Wittern; Horst Wenck; Franz Staeb; Thomas Blatt
Journal:  Mol Cell Biochem       Date:  2007-07-28       Impact factor: 3.396

Review 2.  The management of conditioned nutritional requirements in heart failure.

Authors:  Marc L Allard; Khursheed N Jeejeebhoy; Michael J Sole
Journal:  Heart Fail Rev       Date:  2006-03       Impact factor: 4.214

3.  Mitochondrial intermembrane inclusion bodies: the common denominator between human mitochondrial myopathies and creatine depletion, due to impairment of cellular energetics.

Authors:  E O'Gorman; T Piendl; M Müller; D Brdiczka; T Wallimann
Journal:  Mol Cell Biochem       Date:  1997-09       Impact factor: 3.396

4.  Stimulation of mitochondrial gene expression and proliferation of mitochondria following impairment of cellular energy transfer by inhibition of the phosphocreatine circuit in rat hearts.

Authors:  R J Wiesner; T V Hornung; J D Garman; D A Clayton; E O'Gorman; T Wallimann
Journal:  J Bioenerg Biomembr       Date:  1999-12       Impact factor: 2.945

Review 5.  The creatine kinase system and pleiotropic effects of creatine.

Authors:  Theo Wallimann; Malgorzata Tokarska-Schlattner; Uwe Schlattner
Journal:  Amino Acids       Date:  2011-03-30       Impact factor: 3.520

6.  Recombinant expression and isolation of human L-arginine:glycine amidinotransferase and identification of its active-site cysteine residue.

Authors:  A Humm; E Fritsche; K Mann; M Göhl; R Huber
Journal:  Biochem J       Date:  1997-03-15       Impact factor: 3.857

7.  Crystal structure and mechanism of human L-arginine:glycine amidinotransferase: a mitochondrial enzyme involved in creatine biosynthesis.

Authors:  A Humm; E Fritsche; S Steinbacher; R Huber
Journal:  EMBO J       Date:  1997-06-16       Impact factor: 11.598

Review 8.  Creatine and the creatine transporter: a review.

Authors:  R J Snow; R M Murphy
Journal:  Mol Cell Biochem       Date:  2001-08       Impact factor: 3.396

Review 9.  Amino acids and derivatives, a new treatment of chronic heart failure?

Authors:  Valentina Carubelli; Anna Isotta Castrini; Valentina Lazzarini; Mihai Gheorghiade; Marco Metra; Carlo Lombardi
Journal:  Heart Fail Rev       Date:  2015-01       Impact factor: 4.214

Review 10.  The ABC transporter structure and mechanism: perspectives on recent research.

Authors:  P M Jones; A M George
Journal:  Cell Mol Life Sci       Date:  2004-03       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.